DaHui Lawyers is active in the life sciences and healthcare industry, advising clients on IP, regulatory and licensing matters, as well as market entry, corporate transactions and disputes within the STM sector. The team is headed by founding and managing partner Richard Ma, frequently instructed by foreign investors and multinational companies on multimillion RMB M&A transactions. Edward Lu specialises in cross-border litigation and has extensive experience in government investigations and advertising compliance.
Legal 500 Editorial commentary
Key clients
- Altek Group
- Amador Bioscience
- AngioDynamics, Inc.
- Anji Pharmaceutical
- Aura Argan Inc.
- Baodijin Healthcare Industries
- Bayer China
- BlephEx
- BMJ (British Medical Journal)
- China International Capital Corporation Limited aka CICC
- China Merchants Healthcare
- ClearVue Partners
Work highlights
Advising a life sciences company on the sale of one of its divisions in a deal worth nearly USD 2 billion.
Represented a world-class agricultural and chemical company at SIAC in an arbitration arising from a joint venture dispute with a preeminent agricultural company.
Represented a transnational contract research organisation (CRO) embroiled in a complex cross-border dispute with the founder of an acquired company over unpaid cash and separation issues.
Practice head
Richard Ma
Other key lawyers
Edward Lu